ECSP003434A - NEW COMPOUNDS - Google Patents

NEW COMPOUNDS

Info

Publication number
ECSP003434A
ECSP003434A ECSP003434A ECSP003434A EC SP003434 A ECSP003434 A EC SP003434A EC SP003434 A ECSP003434 A EC SP003434A EC SP003434 A ECSP003434 A EC SP003434A
Authority
EC
Ecuador
Prior art keywords
compound
new compounds
provides
containing peaks
peaks
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Andrew Simon Craig
Robert Gordon Giles
Michael John Sasse
Paul David James Blackler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003434 priority Critical patent/ECSP003434A/en
Publication of ECSP003434A publication Critical patent/ECSP003434A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Monohidrato de hidrocloruro de 5-[4-[2-(N-metil-N-(2-piridil)amino)etoxi]bencil]tiazolidina-2,4-diona, caracterizado porque: (i) proporciona un espectro infrarrojo que contiene picos a 3.358, 2.764, 1.245, 833 y 760 cm-1; y/o (ii) proporciona un modelo de difracción de rayos X a través de polvo (XRPD) que contiene picos a 15,0, 17,7, 23,0, 30,0 y 31,4o2O; un procedimiento para prpeparar dicho compuesto, una composición farmacéutica que contiene dicho compuesto y el uso de dicho compuesto en medicina.5- [4- [2- (N-Methyl-N- (2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione hydrochloride monohydrate, characterized in that: (i) provides an infrared spectrum containing peaks at 3,358, 2,764, 1,245, 833, and 760 cm-1; and / or (ii) provides a X-ray powder diffraction pattern (XRPD) containing peaks at 15.0, 17.7, 23.0, 30.0, and 31.4o2O; a procedure for preparing said compound, a pharmaceutical composition containing said compound and the use of said compound in medicine.

ECSP003434 2000-04-27 2000-04-27 NEW COMPOUNDS ECSP003434A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003434 ECSP003434A (en) 2000-04-27 2000-04-27 NEW COMPOUNDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003434 ECSP003434A (en) 2000-04-27 2000-04-27 NEW COMPOUNDS

Publications (1)

Publication Number Publication Date
ECSP003434A true ECSP003434A (en) 2000-07-21

Family

ID=42041062

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003434 ECSP003434A (en) 2000-04-27 2000-04-27 NEW COMPOUNDS

Country Status (1)

Country Link
EC (1) ECSP003434A (en)

Similar Documents

Publication Publication Date Title
UY26121A1 (en) NEW PHARMACEUTICAL COMPOUND
AR023564A1 (en) A POLYMORPHIC FORM OF SALT OF THE MALEIC ACID DERIVED FROM TIAZOLIDINE-2,4 DIONA, A PHARMACEUTICAL COMPOSITION AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
UY25304A1 (en) HYDRATED FORM OF ROSIGLITAZONE MALEATE
CY1105354T1 (en) A THIAZOLIDINODIONE DERIVATIVE AND ITS USE AS AN ANTI-DIABETIC
EA200101101A1 (en) NEW PHARMACEUTICAL PREPARATION
EA200101102A1 (en) NEW PHARMACEUTICAL PREPARATION
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
PT1349855E (en) 5-`4-`2-(n-methyl-n- (2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione mesylate salt
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
ECSP003434A (en) NEW COMPOUNDS
ATE329914T1 (en) ROSIGLITAZONE EDISYLATE AND THEIR USE AS ANTIDIABETIC DRUGS
ECSP003435A (en) NEW COMPOUNDS
AP2002002673A0 (en) Thiazolidinedione salt for the treatment of diabetes mellitus.
HK1057204A1 (en) A thiazolidinedione derivative and its use as antidiabetic
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
CY1107767T1 (en) THIAZOLIDINODIONI PRODUCER AND USE OF IT AS ANTIBIOTIC
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
ECSP003438A (en) NEW COMPOUNDS
AP1738A (en) Sodium salts of 5-[4-[2-(N-Methyl -N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
ECSP003436A (en) NEW COMPOUNDS
ECSP982779A (en) A HYDRATE OF MALEIC ACID SALT, PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION AND ITS USE IN MEDICINE